Lv3
308 积分 2025-03-07 加入
T cell lymphomas: cancers of aberrant immune synapse signalling
1个月前
已完结
Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: a prospective cohort study from the international T-cell Project
2个月前
已完结
Beyond suppression: the paradox of JAK inhibitors as amplifiers of cancer immunotherapy
3个月前
已完结
Epstein–Barr Virus‐Associated T/NK‐Cell Neoplasms
3个月前
已关闭
Expert Consensus on Cytomegalovirus Management in Recipients of CAR‐T Cell and Bispecific Antibody Therapies
3个月前
已完结
Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial
5个月前
已完结
EZH2 inhibitor Tazemetostat synergizes with JQ-1 in esophageal cancer by inhibiting c-Myc signaling pathway
9个月前
已完结
EZH2 inhibition enhances T cell immunotherapies by inducing lymphoma immunogenicity and improving T cell function
9个月前
已完结
皖公网安备34019202002308
